🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Turkey / NCT07524933
Active, not recruiting Not applicable

Comparison of the Effectiveness of Nerve Hydrodissection With Saline Injection of 5% Dextrose in Carpal Tunnel Syndrome.

NCT07524933 · tracked via the Priya Life Science Turkey tracker
Phase
Not applicable
Started
2026-01-08
Last updated
2026-04-13

Condition(s) studied

Conditions

Investigational drug(s) / intervention(s)

Nerve Hydrodissection with 5% Dextrose

Nerve Hydrodissection with 5% Dextrose: Injection therapy

Study summary

Comparison of the effectiveness of nerve hydrodissection with saline injection of 5% dextrose in carpal tunnel syndrome.

Eligibility

Sex
ALL
Min age
18 Years
Max age
80 Years
Healthy volunteers
No
Inclusion Criteria: * Adults aged 18-80 years * Clinical and electrophysiological diagnosis of mild to moderate carpal tunnel syndrome * Symptom duration of at least 3 months * Both male and female participants * Patients who have not responded adequately to conservative treatment * Patients who do not wish to undergo surgical treatment * Ability to provide informed consent Exclusion Criteria: * Severe or very severe carpal tunnel syndrome based on EMG findings * Previous injection therapy for carpal tunnel syndrome * Prior wrist or carpal tunnel surgery * Polyneuropathy or other peripheral neuropathies * Cervical radiculopathy or proximal median nerve entrapment * Brachial plexopathy or thoracic outlet syndrome * Pregnancy * Malignancy * Local or systemic infection * Cognitive impairment affecting cooperation * Systemic diseases affecting the median nerve (e.g., uncontrolled diabetes mellitus, thyroid disorders)

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Antalya Eğitim Araştırma Hastanesi Antalya Turkey (Türkiye)

More Antalya Training and Research Hospital trials in Turkey

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07524933 on ClinicalTrials.gov ↗ ← All trials in Turkey